Rob Sterling is an experienced business development professional with a history of leadership roles within the pharmaceutical and biotech industries. As VP of Business Development for Nanoform in the USA and previously as Director of Business Development at Sever Pharma Solutions, Rob has demonstrated expertise in strategic growth. Additional roles include membership on the Business Advisory Board for Ichor Therapeutics, and involvement in business and corporate development at Cascade Biotherapeutics. Previously, Rob served as VP of Business Development & Licensing and Operations at Provepharm. Rob's educational background includes a Bachelor of Arts in Secondary Education from Penn State University, complemented by foundational education at Trumansburg Central School.